Results

Total Results: 1,269 records

Showing results for "author year description".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-protocol.pdf
    April 17, 2024 - Five-year survival rates range from 100% for men with local disease at diagnosis to 35.4% for men with … sufficient data are available, we will use standardization frameworks such as the Template for Intervention Description … Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. … Better reporting of interventions: template for intervention description and replication (TIDieR) checklist … to previous versions; and a table with the date of each amendment, which will be accompanied by a description
  2. effectivehealthcare-admin.ahrq.gov/products/child-growth-development-outcomes/protocol
    November 01, 2024 - cow milk, regardless of milk fat content, should not be included in an infant’s diet until after 1 year … Microsoft Excel® for data extraction for each Key Question that includes study characteristics (e.g., author … , year of publication and data collection, country, study design, inclusion and exclusion criteria), … Criteria for assessing the risk of bias of individual studies 51 Rating Description and Criteria Low … Description of the strength of evidence grades Strength of Evidence Description High Very confident that
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
    June 17, 2014 - large number of the 500,000 youth with special health care needs who transition to adult care each year … We have added a description of outcomes to the Background section. … Peer Reviewer 1 Methods The author do not specific the procedure that was employed to access the grey … We have added information to the methods description to make this clearer. … We have added information to the methods description to make this clearer.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gout-diagnosis-disposition-160727.pdf
    February 24, 2016 - Co-Author Dr. Fitzgerald may be a resource for this. … We have replaced the word "accepted" with "validated," although we are not sure this description is … Space is limited in the abstract and didn't permit a full description. … The AHRQ systematic review report format specifies we begin the Results section with a description … We have clarified it in the description, which we moved down in that section.
  5. effectivehealthcare-admin.ahrq.gov/products/glaucoma-screening/research-protocol
    December 01, 2019 - with a median age-adjusted prevalence of 4.6% and 1.6% among blacks and whites, respectively (based on year … A detailed description of Food and Drug Administration (FDA) approval status, indications, and warnings … Timing Outcomes for Key Questions 1, 2, 4, 5, and 6 will be assessed at 1 year of follow-up and at … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  6. effectivehealthcare-admin.ahrq.gov/products/cesarean-birth-2010/research-protocol
    December 01, 2019 - ethnicity, maternal age, and other factors, with the highest rates in the southeastern States. 2 One 2007 author … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … limiting the ability to apply interventions to other populations or other settings, such as inadequate description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  7. effectivehealthcare-admin.ahrq.gov/products/phenylketonuria/research-protocol
    December 01, 2019 - One comment suggested that "cognitive decline" may not be the most accurate outcome description, so we … evidence table may vary by KQ as is appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … limiting the ability to apply interventions to other populations or other settings, such as inadequate description
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
    August 23, 2010 - These two types of nonmelanomatous (NMSC) lesions, responsible for more than 800,000 cases per year, … .4 One study found that “melanoma incidence rates had doubled in all socioeconomic groups over a 10-year … period”.5 Another study found that melanoma incidence rates have increased by 3% per year in white … From qualified studies, we will extract data on the citation (first author name, journal and year of
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
    November 18, 2024 - cow milk, regardless of milk fat content, should not be included in an infant’s diet until after 1 year … Microsoft Excel® for data extraction for each Key Question that includes study characteristics (e.g., author … , year of publication and data collection, country, study design, inclusion and exclusion criteria), … Criteria for assessing the risk of bias of individual studies50 Rating Description and Criteria Low … Description of the strength of evidence grades Strength of Evidence Description High Very confident
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
    September 01, 2011 - the differentiation into Tiers 1-3 and MMD alone or mixed groups, I struggled to find a compelling description … Earlier this year, Janicak and colleagues published the results of a 6-month naturalistic follow-up … Peer Reviewer #8 General Nemeroff [et al., PNAS, 2003—and Michael Thase was a co-author] studied … "Two-year outcome of vagus nerve stimulation in treatment-resistant depression." … "Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes."
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
    October 11, 2019 - The current qualitative description is sufficient according to our clinical experts and other peer … Risk trajectories of readmission and death in the first year after hospitalization for chronic obstructive … Descriptions were presented at the end of study description for each KQ, pages 13, 22, 42, 45. … Peer reviewer #4 Results Page 42/302: Current description of the Evidence Base is superficial and does … This comment applies to the description of evidence base for all key questions.
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
    May 27, 2014 - Patients were included in this trial if they had any hospitalization within the past year (and were … According to Table 1 in that study, approximately 15% had no hospitalization within the past year. … The librarian who assisted with the search and retrieval of articles is listed as an author in the … Requests on where/how to locate included articles can be sent to the corresponding author. 146 Peer … Data from the 2004 Naylor article was obtained from the author (in the original publication, it was
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
    January 07, 2013 - The audience of this report is not explicitly stated but assumed based on the general description of … Peer Reviewer #3 General Description of the studies suggests none was an RCT, but the table includes … The revised “Description of Included Studies” section for KQ2 states, “Thirty-three of the 48 studies … The report is generally very well-written and is exhaustive in the description of the approach. … As suggested, we have modified our description of the control group to clarify.
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
    September 01, 2011 - Reviewer 1 Discussion / Conclusion The report provides a balanced description of the relevant … 64 Table 12 P 80 - Table 12 - later in the text there is explanation as to why AZ is listed as an author … We judged it is more informative to list Astra Zeneca as the author than "anonymous" TEP #1 Results … Typical antipsychotics have Tardive dyskinesia rates of 7% per year of exposure, while atypicals range
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
    January 01, 2010 - These spreadsheets will allow each author to count key data points, such as study location, study type … evidence table will vary by key question, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
    December 09, 2009 - These spreadsheets will allow each author to count key data points, such as study location, study type … evidence table will vary by key question, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
    December 01, 2010 - The findings and conclusions in this document are those of the author(s), who are responsible for its … Description of study design classification tools rejected for further evaluation................8 Table … Classification of studies: Round 1 Study (author, year) Reference Standard NonR trial RCT … Classification of studies: Round 1 (continued) Study (author, year) Reference Standard NonR … Classification of studies: Round 2 Study (author, year) Reference Standard NonR trial RCT
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/inguinal-hernia_disposition-comments.pdf
    August 17, 2012 - Introduction: In the abstract introduction, the sentence "in children, incidence..." follows right after description … The experienced surgeon will discredit it because of the major errors in description of the procedures … We have two poplulation-based studies in press that suggest that the 770,000 hernia repairs per year … Christine Chang, AHRQ Results overall description of studies. … This study was funded by AHRQ and the American College of Surgeons, and the lead author disclosed financial
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
    November 01, 2010 - The description of Applied Behavior Analysis (ABA) here is used to provide a general description of … Methods good description, and sound methods. … For instance, a study on which I was an author (Howard et al, 2005) is described incorrectly as providing … study measured and found treatment vs control group differences on at least outcome (language) a 1 year … individuals participating as peer reviewers and authors; AHRQ reports typically do not include additional author
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-knee-update-disposition-archived.pdf
    May 04, 2017 - It states the searches commenced with the year 2006 but what was the end date of the reviews? … We have clarified the description of self- management programs in the PICOTS table. … We have added a description of our effect estimates in the Methods section of the main text under … We used the same author name to show it was the same study but have now changed it to the Healthy … We included a description of the limitations of our review.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: